* Exposure to pesticides and welding hastens the age-at-onset of Parkinson’s disease (Gamache et al, 2019) [Epub ahead of print]

* Common and rare GCH1 variants are associated with Parkinson’s disease (Rudakou et al, 2019)

* SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson’s disease (Alcalay et al, 2019)

* Parkinson’s disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms (Blauwendraat et al, 2019)

* Transcranial magnetic stimulation improves cognition over time in Parkinson’s disease (Trung et al, 2019)

* Why Is Aging a Risk Factor for Cognitive Impairment in Parkinson’s Disease? A Resting State fMRI Study (Nagano-Saito et al, 2019)

* TOX3 Variants Are Involved in Restless Legs Syndrome and Parkinson’s Disease with Opposite Effects (Mohtashami et al, 2018)

* Association study of essential tremor genetic loci in Parkinson’s disease (Ross et al, 2018)

* Full sequencing and haplotype analysis of MAPT in Parkinson’s disease and rapid eye movement sleep behavior disorder (Li  et al, 2018)

* Sequencing of the GBA coactivator, Saposin C, in Parkinson disease (Ouled Amar Bencheikh et al, 2018)

* Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease (Blauwendraat et al, 2018)

* The GBA p.Trp378Gly mutation is a probable French-Canadian founder mutation causing Gaucher disease and synucleinopathies (Ruskey et al, 2018)

* White matter degeneration profile in the cognitive cortico-subcortical tracts in Parkinson’s disease. Movement Disorders. (Hanganu et al, 2018)

* Cardinal motor features of Parkinson’s disease coexist with peak-dose choreic-type drug-induced dyskinesia. Parkinson’s symptoms coexist with dyskinesia (Goubault et al, 2018)

*  Cranio-Caudal Kinematic Turn Signature Assessed with Inertial Systems As a Marker of Mobility Deficits in Parkinson’s Disease (Lebel et al, 2018)

* Using inertial sensors to automatically detect and segment activities of daily living in people with Parkinson’s disease (Nguyen et al, 2018)

* The influence of vascular risk factors on cognitive function in early Parkinson’s disease (Doiron et al, 2018)

* Auto detection and segmentation of daily living activities during a Timed Up and Go task in people with Parkinson’s disease using multiple inertial sensors (Nguyen et al, 2017)

* REM Sleep Behavior Disorder and Cognitive Impairment in Parkinson’s Disease (Jozwiak et al, 2017)

* Depressive symptoms in Parkinson’s disease correlate with cortical atrophy over time (Hanganu et al, 2017)

* Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson’s disease (Blauwendraat et al, 2017)

* RIC3 variants are not associated with Parkinson’s disease in French-Canadian and French (Ross et al, 2017)

* Dementia Predictors in Parkinson Disease: A Validation Study (Anang et al, 2017)

* Smoking history is associated to cognitive impairment in Parkinson’s disease (Doiron et al, 2017)

* A 12-Week Cycling Training Regimen Improves Gait and Executive Functions Concomitantly in People with Parkinson’s Disease (Nadeau et al, 2017)

* Structural Neuroimaging Markers of Cognitive Decline in Parkinson’s Disease (Hanganu & Monchi, 2016)

* Markers of cognitive decline in PD: The case for heterogeneity (Monchi et al, 2016)

* Risk Factor Profile in Parkinson’s Disease Subtype with REM Sleep Behavior Disorder (Jacobs, 2016)

* The role of the melanoma gene MC1R in Parkinson disease and REM sleep behavior disorder (Gan-Or et al, 2016)

* Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson’s disease (Ross et al, 2016)

* Patterns of Longitudinal Neural Activity Linked to Different Cognitive Profiles in Parkinson’s Disease (Nagano-Saito et al, 2016)

* Tango for treatment of motor and non-motor manifestations in Parkinson’s disease: a randomized control study (Romenets et al, 2015)

* Influence of depressive symptoms on dopaminergic treatment of Parkinson’s disease (Hanganu, 2014)

————————————————————————————————————————-

Congresses

Professional exposure to pesticides and heavy metals hastens the onset of Parkinson disease (April 2017)

American Academy of Neurology Congress